Antihypertensive effects of sulforaphane

Persistent hypertension is associated with a greater incidence of organ damage and conditions such as stroke, heart failure and end–stage kidney disease, which results in increased cardiovascular (CV) morbidity and mortality. Among the patients receiving antihypertensive treatment, the level of adequate blood pressure (BP) control (

Name thesis:degree_name

Doctor of Philosophy (Ph.D.)

Level thesis:degree_level

Doctoral

Discipline thesis:degree_discipline

Pharmacology

Grantor

University of Saskatchewan

Year dc:date.issued

2011

Author dc:creator

• Banigesh, Ali

Advisors dc:contributor.advisor

• Juurlink, Bernhard
• Wu, L.

Committee members dc:contributor.committeemember

• Richardson, J. Steven
• Wang, Hui Di
• Kulyk, W.
• Desai, K.
• Lee, P.

• SHRsp
• sulforaphane
• hypertension
• phase2 protein inducer

Language dc:language.iso

en_US

Handle dc:identifier.uri

https://hdl.handle.net/10388/etd-03292011-144232

OAI identifier oai:identifier

oai:harvest.usask.ca:10388/etd-03292011-144232